1.

Cost-effectiveness planes of the sensitivity analyses.

1.

Flowchart of study participants.

1.

Cost-effectiveness plane reflecting the probability that blended ACT is cost-effective compared to CBT in terms of treatment responders.

1.

Cost-effectiveness plane reflecting the probability that blended ACT is cost-effective compared to CBT in terms of QALYs (cost-utility).

1.

Acceptability curve reflecting the probability that blended ACT is cost-effective compared to CBT in terms of QALYs (cost-utility) at different willingness-to-pay ceilings.

1.

Baseline characteristics of study sample.

1.

Mean costs and outcomes by condition over assessments.

1.

Result of the main analyses (cost-effectiveness and cost-utility) and sensitivity analyses.

1.

Spatial distribution of cholera cases presenting to health facilities in Sabah between 2015–2020 (N = 705) .

2.

Spatial distribution of cholera cases presenting to health facilities in Sabah between 2015–2020 (N = 705) .

3.

Spatial distribution of cholera cases presenting to health facilities in Sabah between 2015–2020 (N = 705) .

1.

Tau statistic for cholera in Sabah, 2015–2020.

2.

Tau statistic for cholera in Sabah, 2015–2020.

3.

Tau statistic for cholera in Sabah, 2015–2020.

4.

Tau statistic for cholera in Sabah, 2015–2020.

5.

Tau statistic for cholera in Sabah, 2015–2020.

6.

Tau statistic for cholera in Sabah, 2015–2020.

7.

Tau statistic for cholera in Sabah, 2015–2020.